drugset / Trial / NCT06616675

Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1

NCT06616675

Phase 4 Completed 42 enrolled Hospital Universitário Professor Edgard Santos
RandomizedParallel-groupOpen-labelTreatment

Summary

In this study the investigators compare the parasacral transcutaneous electric nerve stimulation (PTENS) treatment with Darifenacin to improve OAB symptoms in patients infected with HTLV-1.

Timeline

Start
2022-03-16
Primary completion
2023-12-20
Completion
2023-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Darifenacin Small molecule 15 mg